Back
Revance Therapeutics Stock Predictions
Sponsored
RVNC
Sponsored
Free 23-page book shares my #1 indicator to use
Here's the 23-page free book.
Sell
20
RVNC
Revance Therapeutics
Last Price:
5.82
Seasonality Move:
-5.59%
7 Day Trial
ALL ACCESS PASS
$
7
"The Next Apple?" - Mode's Growth Story is Turning Heads
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Revance Therapeutics Stock Forecast
- Over the next 52 weeks, Revance Therapeutics has on average historically risen by 5.2% based on the past 10 years of stock performance.
- Revance Therapeutics has risen higher in 5 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
-
Is Revance Therapeutics Stock Undervalued?
The current Revance Therapeutics [RVNC] share price is $5.81. The Score for RVNC is 20, which is 60% below its historic median score of 50, and infers higher risk than normal. - RVNC is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
Will Revance Therapeutics Stock Go Up Next Year?
- Over the next 52 weeks, Revance Therapeutics has on average historically risen by 5.2% based on the past 10 years of stock performance.
Revance Therapeutics Stock Rating
Sell
20
Revance Therapeutics (RVNC)
is a Sell
Is Revance Therapeutics overpriced?
- Revance Therapeutics has risen higher in 5 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
Revance Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
revance.com
52-Week Data
52-Week High:
13.12
52-Week Low:
2.30
Prediction Charts
Market Cap:
605.29M
Price in USD:
5.81
Volume:
5.42M
Beta:
1.03
Technical Analysis
SMA50:
5.27
SMA100:
4.16
SMA200:
5.03
52-Wk Change:
-55.8%
Stock Predictions
-
Is Revance Therapeutics stock public?
Yes, Revance Therapeutics is a publicly traded company. -
What is the Revance Therapeutics stock quote today?
The Revance Therapeutics stock price is 5.81 USD today. -
How to buy Revance Therapeutics stock online?
You can buy Revance Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Sep-3 | 6.57 | 6.59 | 6.59 | 6.57 |
Sep-4 | 6.58 | 6.58 | 6.59 | 6.57 |
Sep-5 | 6.58 | 6.57 | 6.58 | 6.55 |
Sep-6 | 6.56 | 6.57 | 6.58 | 6.54 |
Sep-9 | 6.58 | 6.59 | 6.59 | 6.57 |
Sep-10 | 6.57 | 6.57 | 6.58 | 6.55 |
Sep-11 | 6.57 | 6.58 | 6.59 | 6.56 |
Sep-12 | 6.58 | 6.56 | 6.59 | 6.54 |
Sep-13 | 6.58 | 6.55 | 6.59 | 6.54 |
Sep-16 | 6.54 | 5.97 | 6.57 | 5.44 |
Sep-17 | 6.02 | 5.97 | 6.27 | 5.85 |
Sep-18 | 5.95 | 5.99 | 6.30 | 5.90 |
Sep-19 | 6.03 | 5.85 | 6.05 | 5.72 |
Sep-20 | 5.85 | 5.81 | 5.91 | 5.74 |
Revance Therapeutics Earnings
Revance Therapeutics Earnings Report: Per Share Revance Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Revance Therapeutics Forecast Revenue Growth
Revance Therapeutics Stock Analysis: Historical quarterly revenues per share for Revance Therapeutics and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $0.54 per share, an increase next quarter of $0.40 per share, an increase this year of $2.64 per share, and an increase next year of $0.70 per share.
* Revance Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.